NOVELION THERAPEUTICS INC's ticker is NVLNF and the CUSIP is 67001K202. A total of 80 filers reported holding NOVELION THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 2.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $18,000 | -45.5% | 26,000 | -43.5% | 0.00% | -50.0% |
| Q3 2019 | $33,000 | -8.3% | 46,000 | 0.0% | 0.00% | -20.0% |
| Q2 2019 | $36,000 | -36.8% | 46,000 | 0.0% | 0.01% | -37.5% |
| Q1 2019 | $57,000 | +46.2% | 46,000 | 0.0% | 0.01% | +33.3% |
| Q4 2018 | $39,000 | -49.4% | 46,000 | +76.9% | 0.01% | -40.0% |
| Q3 2018 | $77,000 | -19.8% | 26,000 | 0.0% | 0.01% | -28.6% |
| Q2 2018 | $96,000 | +5.5% | 26,000 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $91,000 | +12.3% | 26,000 | 0.0% | 0.01% | +16.7% |
| Q4 2017 | $81,000 | -42.6% | 26,000 | +30.0% | 0.01% | -47.8% |
| Q3 2017 | $141,000 | -23.8% | 20,000 | 0.0% | 0.02% | -28.1% |
| Q2 2017 | $185,000 | -33.7% | 20,000 | -23.1% | 0.03% | -34.7% |
| Q1 2017 | $279,000 | -7.9% | 26,000 | -27.8% | 0.05% | -7.5% |
| Q4 2016 | $303,000 | – | 36,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|